The future of #healthcare is here, and it includes #telehealth . The pandemic proved that telehealth is not just a viable alternative to an in-person visit with a provider but an effective way to expand access to care. buff.ly/3UfMKIT

Cost-effective biosimilars like Yusimry offer a win-win solution for employers and employees, saving money without sacrificing quality of care. Yet, PBMs stand in the way of these potential savings. buff.ly/44ex3Ge

Raising the #Medicare eligibility age is one of many solutions to keep the program afloat. We need to adapt to our country's changing demographics and fiscal realities. buff.ly/3xJp1sR

It's time to hold UnitedHealth Group accountable not just for cybersecurity lapses but also for the financial harm inflicted on patients by PBMs. Congress must act to bring transparency to drug pricing. buff.ly/4dfLwpK

Remote care shouldn't have an expiration date. It's time for Congress to make telehealth a lasting part of Medicare. buff.ly/3UfMKIT

PBMs are the barrier preventing the widespread adoption of cost-effective biosimilars, which could save the entire healthcare system billions. buff.ly/44ex3Ge

“Manipulate” is the correct word. #PBMs consistently this & much more to the detriment of patients & access while lining their own pockets.

It's time for Congress to confront the shadowy practices of pharmacy benefit managers (PBMs) that drive up prescription drug costs, often at the expense of patient well-being. buff.ly/4dfLwpK

Telehealth isn't just a temporary fix -- it's a lifeline for many seniors. Congress should act to ensure #Medicare beneficiaries have continued access to remote care. buff.ly/3UfMKIT

As long as PBMs are financially incentivized to push patients toward the most expensive treatments, savings won’t fully materialize. Lawmakers should ensure that PBMs can’t manipulate the drug market to the detriment of patients and their employers. buff.ly/44ex3Ge

Biden's plan to raise taxes won't solve Medicare's financial woes. We need structural reforms that address the root of the problem. #Medicare buff.ly/3xJp1sR

The state Assembly’s Health Committee advanced Assembly Bill 2200 this week. The bill would ban private health insurance and force all state residents into “CalCare,” a government-run health plan:

pacificresearch.org/californias-si…

Demand for medical care will only increase in the years to come, as the U.S. population ages. Meeting that demand will require eliminating the regulations that have long curtailed the supply of care. buff.ly/4aZcos4

Declaring health care as a right might woo some naive voters, but it will do nothing to change the fundamental laws of supply and demand. buff.ly/3U3fGDO

Tennessee is leading the way in removing hurdles for American doctors with international medical degrees. It's time for other states to follow suit and unlock the potential of the physician workforce. buff.ly/4aZcos4

What good is a 'right' to health care if people don't have the freedom to choose affordable insurance or access to lifesaving drugs? buff.ly/3U3fGDO

AB 2200 would create a #singlepayer #healthcare system in CA. Read Pacific Research Institute Spending Watch to learn its impact: 2.8% less economic growth, 333,000 fewer jobs, avg incomes $1200 smaller, & 345,000 more people leaving CA. pacificresearch.org/single-payer-w…

Biden and Sanders celebrate 'beating Big Pharma,' but at what cost? Their price controls jeopardize the future of drug development and American's access to cutting-edge treatments. buff.ly/3W3fiYl

Biosimilars could save the healthcare system billions | Sally Pipes trib.al/96XmHzd trib.al/96XmHzd

It's time to rethink how we approach healthcare for low-income Americans. Market-oriented reforms offer promising solutions to improve outcomes for all. buff.ly/3JjM8wv